- Indapamide
-
Indapamide Systematic (IUPAC) name 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)- 3-sulfamoyl-benzamide Clinical data AHFS/Drugs.com monograph MedlinePlus a684062 Pregnancy cat. ? Legal status POM Routes Oral tablet Pharmacokinetic data Protein binding 71-79% Metabolism Hepatic Half-life 14-18 hours Identifiers CAS number 26807-65-8 ATC code C03BA11 PubChem CID 3702 DrugBank APRD01031 ChemSpider 3574 UNII F089I0511L KEGG D00345 ChEMBL CHEMBL406 Chemical data Formula C16H16ClN3O3S Mol. mass 365.835 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Indapamide is a non-thiazide sulphonamide diuretic drug marketed by Servier, generally used in the treatment of hypertension, as well as decompensated cardiac failure. The US trade name for indapamide is Lozol.[1] Indapamide is marketed as Natrilix outside of the US, as Insig in Australia. Combination preparations with perindopril (an ACE inhibitor antihypertensive) are also available.
It is described as a thiazide-like diuretic.[2]
Contents
Form and composition
Indapamide is available generically as 1.25 mg and 2.5 mg non-scored tablets.[3]
Indications
Hypertension and edema due to congestive heart failure. Indapamide has been proven in the HYVET trial to reduce stroke and all cause mortality when given with or without perindopril to people over the age of 80 for the treatment of hypertension.
Dosage and administration
The adult dosage is 1.25 to 5 mg by orally once daily usually in the morning.
Contraindications
Indapamide is contraindicated in known hypersensitivity to sulfonamides, severe renal failure, hepatic encephalopathy or severe hepatic failure and hypokalemia (low blood potassium levels).
There is insufficient safety data to recommend indapamide use in pregnancy or breastfeeding.
Interactions
Caution is advised in the combination of indapamide with lithium and nonantiarrhythmic drugs causing wave burst arrhythmia (astemizole, bepridil, IV erythromycin, halofantrine, pentamidine, sultopride, terfenadine, vincamine).
Precautions
Monitoring of potassium and uric acid serum levels is recommended, especially in subjects with a predisposition or a sensitivity to hypokalemia and in patients with gout.
Adverse effects
Commonly reported adverse events are hypokalemia (low potassium levels), fatigue, orthostatic hypotension (blood pressure decrease on standing up) and allergic manifestations.
Overdosage
Symptoms of overdosage would be those associated with a diuretic effect: electrolyte disturbances, hypotension, and muscular weakness. Treatment should be symptomatic, directed at correcting the electrolyte abnormalities.
References
Antihypertensives: diuretics (C03) Sulfonamides
(except EA)CA inhibitors (at PT)Thiazide-likes (primarily DCT)Quinethazone • Clopamide • Chlortalidone • Mefruside • Clofenamide • Metolazone • Meticrane • Xipamide • Indapamide • Clorexolone • FenquizonePotassium-sparing (at CD) ESC blockersOsmotic diuretics (PT, DL) VAs (DCT and CD) vaptans: Conivaptan • Mozavaptan • Satavaptan • Tolvaptan
tetracyclines: DemeclocyclineOther Categories:- Thiazides
- Diuretics
- Benzamides
- Indoles
- Organochlorides
- Servier
Wikimedia Foundation. 2010.